About Us Services Careers FAQ Contact Us 0
Home Healthcare IT Biosimilars Market Size, Industry Worth US$ 84.12 billion By 2031
Biosimilars Market
Biosimilars Market

Biosimilars Market Size, Share & Trends Analysis Report By Product (Recombinant Non-Glycosylated Proteins, Recombinant Glycosylated Proteins), By Applications (Oncology, Blood Disorder, Growth Hormonal Disorders, Rheumatoid Arthritis, Chronic and Autoimmune Diseases), By Manufacturing Type (In-house manufacturing, Contract Manufacturing) and By Region(North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2023-2031

Report Code: SRHI544DR
Last Updated : Dec 28, 2023
Author : Straits Research
Starting From
USD 1850
Buy Now
File Formats

Market Segmentation

  1. Biosimilars Market, By Product (2021-2031)
    1. Recombinant Non-Glycosylated Proteins
    2. Recombinant Glycosylated Proteins
  2. Biosimilars Market, By Applications (2021-2031)
    1. Oncology
    2. Blood Disorder
    3. Growth Hormonal Disorders
    4. Rheumatoid Arthritis
    5. Chronic and Autoimmune Diseases
  3. Biosimilars Market, By Manufacturing Type (2021-2031)
    1. In-house manufacturing
    2. Contract Manufacturing
    1. North America
      1. North America Biosimilars Market, By Product
        1. Recombinant Non-Glycosylated Proteins
          1. Recombinant Glycosylated Proteins
          2. North America Biosimilars Market, By Applications
            1. Oncology
              1. Blood Disorder
                1. Growth Hormonal Disorders
                  1. Rheumatoid Arthritis
                    1. Chronic and Autoimmune Diseases
                    2. North America Biosimilars Market, By Manufacturing Type
                      1. In-house manufacturing
                        1. Contract Manufacturing
                        2. U.S.
                          1. U.S. Biosimilars Market, By Product
                            1. Recombinant Non-Glycosylated Proteins
                              1. Recombinant Glycosylated Proteins
                              2. U.S. Biosimilars Market, By Applications
                                1. Oncology
                                  1. Blood Disorder
                                    1. Growth Hormonal Disorders
                                      1. Rheumatoid Arthritis
                                        1. Chronic and Autoimmune Diseases
                                        2. U.S. Biosimilars Market, By Manufacturing Type
                                          1. In-house manufacturing
                                            1. Contract Manufacturing
                                          2. Canada
                                        3. Europe
                                          1. Europe Biosimilars Market, By Product
                                            1. Recombinant Non-Glycosylated Proteins
                                              1. Recombinant Glycosylated Proteins
                                              2. Europe Biosimilars Market, By Applications
                                                1. Oncology
                                                  1. Blood Disorder
                                                    1. Growth Hormonal Disorders
                                                      1. Rheumatoid Arthritis
                                                        1. Chronic and Autoimmune Diseases
                                                        2. Europe Biosimilars Market, By Manufacturing Type
                                                          1. In-house manufacturing
                                                            1. Contract Manufacturing
                                                            2. U.K.
                                                              1. U.K. Biosimilars Market, By Product
                                                                1. Recombinant Non-Glycosylated Proteins
                                                                  1. Recombinant Glycosylated Proteins
                                                                  2. U.K. Biosimilars Market, By Applications
                                                                    1. Oncology
                                                                      1. Blood Disorder
                                                                        1. Growth Hormonal Disorders
                                                                          1. Rheumatoid Arthritis
                                                                            1. Chronic and Autoimmune Diseases
                                                                            2. U.K. Biosimilars Market, By Manufacturing Type
                                                                              1. In-house manufacturing
                                                                                1. Contract Manufacturing
                                                                              2. Germany
                                                                              3. France
                                                                              4. Spain
                                                                              5. Italy
                                                                              6. Russia
                                                                              7. Nordic
                                                                              8. Benelux
                                                                              9. Rest of Europe
                                                                            3. APAC
                                                                              1. APAC Biosimilars Market, By Product
                                                                                1. Recombinant Non-Glycosylated Proteins
                                                                                  1. Recombinant Glycosylated Proteins
                                                                                  2. APAC Biosimilars Market, By Applications
                                                                                    1. Oncology
                                                                                      1. Blood Disorder
                                                                                        1. Growth Hormonal Disorders
                                                                                          1. Rheumatoid Arthritis
                                                                                            1. Chronic and Autoimmune Diseases
                                                                                            2. APAC Biosimilars Market, By Manufacturing Type
                                                                                              1. In-house manufacturing
                                                                                                1. Contract Manufacturing
                                                                                                2. China
                                                                                                  1. China Biosimilars Market, By Product
                                                                                                    1. Recombinant Non-Glycosylated Proteins
                                                                                                      1. Recombinant Glycosylated Proteins
                                                                                                      2. China Biosimilars Market, By Applications
                                                                                                        1. Oncology
                                                                                                          1. Blood Disorder
                                                                                                            1. Growth Hormonal Disorders
                                                                                                              1. Rheumatoid Arthritis
                                                                                                                1. Chronic and Autoimmune Diseases
                                                                                                                2. China Biosimilars Market, By Manufacturing Type
                                                                                                                  1. In-house manufacturing
                                                                                                                    1. Contract Manufacturing
                                                                                                                  2. Korea
                                                                                                                  3. Japan
                                                                                                                  4. India
                                                                                                                  5. Australia
                                                                                                                  6. Taiwan
                                                                                                                  7. South East Asia
                                                                                                                  8. Rest of Asia-Pacific
                                                                                                                3. Middle East and Africa
                                                                                                                  1. Middle East and Africa Biosimilars Market, By Product
                                                                                                                    1. Recombinant Non-Glycosylated Proteins
                                                                                                                      1. Recombinant Glycosylated Proteins
                                                                                                                      2. Middle East and Africa Biosimilars Market, By Applications
                                                                                                                        1. Oncology
                                                                                                                          1. Blood Disorder
                                                                                                                            1. Growth Hormonal Disorders
                                                                                                                              1. Rheumatoid Arthritis
                                                                                                                                1. Chronic and Autoimmune Diseases
                                                                                                                                2. Middle East and Africa Biosimilars Market, By Manufacturing Type
                                                                                                                                  1. In-house manufacturing
                                                                                                                                    1. Contract Manufacturing
                                                                                                                                    2. UAE
                                                                                                                                      1. UAE Biosimilars Market, By Product
                                                                                                                                        1. Recombinant Non-Glycosylated Proteins
                                                                                                                                          1. Recombinant Glycosylated Proteins
                                                                                                                                          2. UAE Biosimilars Market, By Applications
                                                                                                                                            1. Oncology
                                                                                                                                              1. Blood Disorder
                                                                                                                                                1. Growth Hormonal Disorders
                                                                                                                                                  1. Rheumatoid Arthritis
                                                                                                                                                    1. Chronic and Autoimmune Diseases
                                                                                                                                                    2. UAE Biosimilars Market, By Manufacturing Type
                                                                                                                                                      1. In-house manufacturing
                                                                                                                                                        1. Contract Manufacturing
                                                                                                                                                      2. Turkey
                                                                                                                                                      3. Saudi Arabia
                                                                                                                                                      4. South Africa
                                                                                                                                                      5. Egypt
                                                                                                                                                      6. Nigeria
                                                                                                                                                      7. The rest of MEA
                                                                                                                                                    3. LATAM
                                                                                                                                                      1. LATAM Biosimilars Market, By Product
                                                                                                                                                        1. Recombinant Non-Glycosylated Proteins
                                                                                                                                                          1. Recombinant Glycosylated Proteins
                                                                                                                                                          2. LATAM Biosimilars Market, By Applications
                                                                                                                                                            1. Oncology
                                                                                                                                                              1. Blood Disorder
                                                                                                                                                                1. Growth Hormonal Disorders
                                                                                                                                                                  1. Rheumatoid Arthritis
                                                                                                                                                                    1. Chronic and Autoimmune Diseases
                                                                                                                                                                    2. LATAM Biosimilars Market, By Manufacturing Type
                                                                                                                                                                      1. In-house manufacturing
                                                                                                                                                                        1. Contract Manufacturing
                                                                                                                                                                        2. Brazil
                                                                                                                                                                          1. Brazil Biosimilars Market, By Product
                                                                                                                                                                            1. Recombinant Non-Glycosylated Proteins
                                                                                                                                                                              1. Recombinant Glycosylated Proteins
                                                                                                                                                                              2. Brazil Biosimilars Market, By Applications
                                                                                                                                                                                1. Oncology
                                                                                                                                                                                  1. Blood Disorder
                                                                                                                                                                                    1. Growth Hormonal Disorders
                                                                                                                                                                                      1. Rheumatoid Arthritis
                                                                                                                                                                                        1. Chronic and Autoimmune Diseases
                                                                                                                                                                                        2. Brazil Biosimilars Market, By Manufacturing Type
                                                                                                                                                                                          1. In-house manufacturing
                                                                                                                                                                                            1. Contract Manufacturing
                                                                                                                                                                                          2. Mexico
                                                                                                                                                                                          3. Argentina
                                                                                                                                                                                          4. Chile
                                                                                                                                                                                          5. Colombia
                                                                                                                                                                                          6. Rest of LATAM

                                                                                                                                                                                      Related Reports

                                                                                                                                                                                      Global Report
                                                                                                                                                                                      The global biostimulants market size is projected to reach USD 7,879 million by 2030, from USD 2,897 million in 2021, and is anticipated to register a CAGR of 11.76% between 2022 and 2030. Biostimulants are natural or synthetic compounds that ca
                                                                                                                                                                                      Buy Now
                                                                                                                                                                                      Global Report
                                                                                                                                                                                      Market Overview The global oncology biosimilar market size was valued at USD 2.92 billion in 2022. It is projected to reach USD 15.62 billion by 2031, growing at a CAGR of 20.5% during the forecast period (2023-2031). Factors such as
                                                                                                                                                                                      Buy Now

                                                                                                                                                                                      Purchase Benefits

                                                                                                                                                                                      • Eligible for a free updated report next year
                                                                                                                                                                                      • Completely customizable scope
                                                                                                                                                                                      • 30% discount on your next purchase
                                                                                                                                                                                      • Dedicated account manager
                                                                                                                                                                                      • Query resolution within 24 hours
                                                                                                                                                                                      • Permission to print the report

                                                                                                                                                                                      We are featured on :

                                                                                                                                                                                      www.straitsresearch.com
                                                                                                                                                                                      © Copyright . All rights Reserved.